Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

148.32 +1.45 (+0.99%)
Streaming Delayed Price Updated: 11:43 AM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
23 24 Next >
News headline image
Robinhood, Under Armour, HubSpot And Some Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy for the Long Haul ↗
Both drugmakers have outperformed the market in the past year. 
Via The Motley Fool
News headline image
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Better Buy: Moderna vs. Axsome Therapeutics ↗
Both of these biotechs offer exciting future prospects. 
Via The Motley Fool
News headline image
Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Got $500? Buy These 2 Unstoppable Stocks ↗
Invest in these stocks if your priority is long-term growth. 
Via The Motley Fool
News headline image
Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
8 Analysts Have This to Say About Axsome Therapeutics ↗
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter: 
Via Benzinga
News headline image
Axsome Therapeutics Announces Availability of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update. 
Via Benzinga
News headline image
Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday ↗
U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
COLA 2023: How Much Did Social Security Benefits Increase for 2023? ↗
Social Security is increasing for 2023 as the Social Security Administration announces an update to the Cost-of-Living Adjustment (COLA). 
Via InvestorPlace
News headline image
Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗
Sometimes, company shares can catch a bid when a rival gets bad news. That's happening with Axsome today as AXSM stock moves higher. 
Via InvestorPlace
News headline image
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges ↗
The company noted "paradoxical results" where the placebo, at times, topped the drug. 
Via Investor's Business Daily
News headline image
Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket ↗
Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech... 
Via Benzinga
News headline image
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday. 
Via Benzinga
News headline image
Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
3 Red-Hot Stocks That Could Continue to Beat the Market ↗
Investors are betting on these companies' revenue growth prospects. 
Via The Motley Fool
News headline image
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years. ↗
All three stocks are worth keeping a lot longer than half a decade. 
Via The Motley Fool
News headline image
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold ↗
Vertex already generates billions in revenue -- but there may be more to come. 
Via The Motley Fool
News headline image
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
These 7 Biotech Stocks Are Set to Boom in 2023 ↗
This article looks at seven biotech stocks that look like good options to move significantly higher in 2023 
Via InvestorPlace
News headline image
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today ↗
Could the stock keep performing? 
Via The Motley Fool
News headline image
Jim Cramer On This Industrial Stock: 'You Don't Know What's In It' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Sociedad Quimica y Minera de Chile (NYSE: SQM) as "fertilizer’s in short supply and so is lithium." 
Via Benzinga
News headline image
3 Stocks Savvy Investors Are Buying Hand Over Fist ↗
These high-flying stocks are defying the bear market. 
Via The Motley Fool
News headline image
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
From Axsome Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.